The study consists of an open-label AXS-14 treatment period followed by a randomised, double-blind treatment period.

Axsome Therapeutics AXSM announced the initiation of the phase III study called FORWARD with the dosing of the first patient, ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

LOS ANGELES (KABC) -- Fibromyalgia and chronic fatigue syndrome are two mysterious and debilitating conditions - and they're often confused with each other. Tiredness, pain, trouble concentrating and ...

When you shop through retailer links on our site, we may earn affiliate commissions. 100% of the fees we collect are used to support our nonprofit mission. Learn more. Fibromyalgia, a potentially ...

CHATHAM, NJ / ACCESSWIRE / February 1, 2024 / Tonix Pharmaceuticals (NASDAQ:TNXP) appears to have a potential new weapon against fibromyalgia for the 6-12 million adults in America suffering from its ...

Fibromyalgia is characterized by spontaneous and widespread pain and affects millions worldwide. There is evidence that the condition is more prevalent among women than men (by about seven to nine ...

A university-based study finds a high prevalence of fibromyalgia symptoms, strongly linked to anxiety, stress, and lifestyle ...

The 4th Circuit ruled an ALJ wrongly discounted a claimant’s fibromyalgia testimony and ordered Social Security benefits ...

San Antonio, TX - Pramipexole (Mirapex, Boehringer Ingelheim), a dopamine-3 agonist already used in the treatment of Parkinson's disease and restless-leg syndrome, has shown efficacy in fibromyalgia ...

Fibromyalgia is typically characterized by widespread pain and is present in around 0.5-10% of the worldwide population with a seven times higher presence among females than males. Apart from pain ...

Lady Gaga revealed this week on Twitter that she suffers from fibromyalgia, sparking curiosity among many of her fans about the chronic health condition, which is characterized by widespread pain and ...